Clinical Trial Update: An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating THC and CBD in multiple sclerosis has completed; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Unspecified THC/CBD formulation (deltas-9-tetrahydrocannabinol and cannabidiol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2012-09-19